Highland Capital Management (Texas)’s Intermolecular, Inc. IMI Stock Holding History

Highland Capital Management (Texas)’s Portfolio IMI Stock Details IMI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	$23K	Buy	+19,700	New	+$22.6K	﹤0.01%	312

Other funds holding IMI

Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return

Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.52% 1-Year Est. Return

Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HGC Investment Management Toronto, Ontario, Canada $451M AUM 8.78% 1-Year Est. Return

K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return

Highland Capital Management (Texas)'s IMI Position: Q2 2019 in Review

Highland Capital Management (Texas) opened a new position in Intermolecular, Inc. (IMI) in Q2 2019: 19,700 shares worth $23K. The stake represents ﹤0.01% of the portfolio and ranks #312 among its holdings.

40 funds tracked by Wall St. Rank hold IMI as of Q2 2019.

Highland Capital Management (Texas) held 19,700 shares of Intermolecular, Inc. worth $23K as of Q2 2019.
Intermolecular, Inc. was a new Highland Capital Management (Texas) position in Q2 2019.
Intermolecular, Inc. made up ﹤0.01% of Highland Capital Management (Texas)'s portfolio in Q2 2019, its #312 holding.
40 funds tracked by Wall St. Rank held Intermolecular, Inc. as of Q2 2019.

Based on Highland Capital Management (Texas)'s 13F filing for Q2 2019, filed 14 Aug 2019.